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In many inflammatory diseases of the central 
nervous system (CNS) neuronal damage deter-
mines permanent neurological deficits. Novel 
strategies for neuroprotection are urgently 
sought and require a detailed understanding of 
the mechanisms underlying neuronal damage. 
The key contribution of cytotoxic CD8+  
T lymphocytes (CTLs) to this process has be-
come increasingly appreciated in recent years 
(Neumann et al., 2002). CTLs are commonly 
recruited to the brain in viral infections, para-
neoplastic disorders (Albert and Darnell, 2004), 
and autoimmune diseases such as multiple scle-
rosis (MS) and Rasmussen’s encephalitis (RE; 
Hauser et al., 1986; Bien et al., 2005; Friese and 
Fugger, 2005; Goverman, 2009). Upon engage-
ment of their cognate peptide–MHC class I 
(MHC-I) complex on target cells, CTLs activate 
an array of effector functions. Cytotoxicity is 
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Neurons are postmitotic and thus irreplaceable cells of the central nervous system (CNS). 
Accordingly, CNS inflammation with resulting neuronal damage can have devastating 
consequences. We investigated molecular mediators and structural consequences of  
CD8+ T lymphocyte (CTL) attack on neurons in vivo. In a viral encephalitis model in mice, 
disease depended on CTL-derived interferon- (IFN-) and neuronal IFN- signaling. 
Downstream STAT1 phosphorylation and nuclear translocation in neurons were associated 
with dendrite and synapse loss (deafferentation). Analogous molecular and structural 
alterations were also found in human Rasmussen encephalitis, a CTL-mediated human 
autoimmune disorder of the CNS. Importantly, therapeutic intervention by IFN- blocking 
antibody prevented neuronal deafferentation and clinical disease without reducing CTL 
responses or CNS infiltration. These findings identify neuronal IFN- signaling as a novel 
target for neuroprotective interventions in CTL-mediated CNS disease.
© 2013 Kreutzfeldt et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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et al., 2006). This indicates that neonatal rLCMV/INDG 
infection fails to trigger a clinically significant CTL response. 
Upon adult infection with LCMV WT (LCMVwt; referred 
to as challenge), carrier mice mount vigorous CTL responses 
against the immunodominant H-2Db–restricted nucleopro-
tein-derived epitope NP396 that is shared between rLCMV/
INDG and LCMVwt. These CTLs infiltrate the CNS gray 
matter, attack NP396-expressing rLCMV/INDG-infected 
neurons, and cause severe disease within 7–10 d after chal-
lenge. The topographical distribution and the composition 
of inflammatory infiltrates in viral déjà vu disease recreate 
histopathological hallmarks of RE. In this human autoim-
mune disease, oligoclonal and therefore putatively antigen-
specific CD8+ T cell populations dominate the histological 
picture and are typically found in direct contact with neu-
rons (Li et al., 1997; Bien et al., 2005). The clinical presenta-
tion of RE is characterized by treatment-refractory epilepsy 
with consequent intellectual decline and hemiparesis, thus 
necessitating surgical resection of affected brain regions. 
A viral contribution to RE pathogenesis has long been sus-
pected but remains to be substantiated (Friedman et al., 
1977; Walter and Renella, 1989; Farrell et al., 1991).
Here, we show that CTL attack on neurons in vivo in-
duces rapid loss of dendrites and synapses rather than neuronal 
depletion. This deafferentation and the resulting disease de-
pend on IFN- signaling from CTLs to neurons but neither 
on Fas- nor on perforin-dependent pathways. Accordingly, 
STAT1 phosphorylation and nuclear translocation together 
with deafferentation represented hallmarks of both the mu-
rine viral déjà vu model and human RE. These findings pro-
vide important new insights into the molecular mechanisms 
and cellular consequences of CTL–neuron interactions in viral 
and autoimmune CNS disorders. This delineates a promising 
new strategy for neuroprotective intervention in immune-
mediated CNS disease.
RESULTS
CTLs mediate deafferentation of antigenic neurons in vivo
We set out to investigate molecular pathways as well as 
morphological and clinical consequences of CTL attack on 
neurons. The viral déjà vu model is characterized by CTL 
infiltrates in the cerebral cortex, basal ganglia, thalamic and 
hypothalamic nuclei, hippocampus, cerebellum, brain stem, 
and some segments of the spinal cord (Merkler et al., 2006). 
First, we assessed whether neuronal loss could account for the 
acute clinical impairment, which starts at day 7–10 after chal-
lenge and includes ataxia, locomotor dysfunction, and occa-
sional paroxysmal seizures. 3 wk after challenge, thus, 2 wk 
after disease onset, neuronal cell densities remained unaltered 
in all anatomical areas under study (Fig. 1). In contrast, tissue 
collected another 5 wk later displayed a minor yet significant 
reduction of neuronal densities in brain stem, spinal cord, and 
hypothalamus but not in cortex dentate gyrus. Thus, albeit a 
consistent finding in later stages, irreversible neuronal drop-
out was unlikely to cause the rapidly developing and severe 
neurological impairments peaking at day 10 after challenge.
typically mediated by perforin-dependent mechanisms and Fas–
FasL (CD95/CD95L) interactions (Stinchcombe and Griffiths, 
2007), but CTLs also secrete cytokines including IFN- and 
TNF. The relative contribution of each of these pathways to 
tissue damage varies greatly and depends on the target cell 
type and tissue (Guidotti et al., 1996; Kägi et al., 1996; Medana 
et al., 2000). At the same time, CTL cytotoxicity and cytokine 
secretion can also both contribute to virus control in the 
CNS (Binder and Griffin, 2001; Shrestha and Diamond, 2007; 
Pinschewer et al., 2010b).
Neurons show limited turnover and regenerative capacity 
yet serve essential functions. Classical concepts have therefore 
suggested that neurons are spared from CTL attack. This 
“immune privilege” has been accredited to limited MHC-I 
expression (Joly et al., 1991), secretion of immunomodulatory 
TGF- (Liu et al., 2006), and expression of Fas-L (Medana 
et al., 2001a). The same mechanisms are also thought to rep-
resent an evolutionary reason why neurons serve as a sanctu-
ary for several RNA and DNA viruses, namely members of 
the Herpes, Paramyxo-, and Arenavirus families (Brown et al., 
1979; Sequiera et al., 1979; ter Meulen et al., 1984; Joly et al., 
1991). Recent studies have shown, however, that infected 
neurons do not escape CTL recognition altogether (McDole 
et al., 2010). For example, CNS-infiltrating CTLs established 
stable peptide/MHC-I–specific contacts with Herpes simplex 
virus– or Borna disease virus–infected neurons, respectively 
(Khanna et al., 2003; Chevalier et al., 2011). In the Theiler’s 
murine encephalomyelitis virus model, depletion of CTLs or 
genetic deficiency in MHC-I or perforin preserved axon in-
tegrity and prevented neurological deficits (Murray et al., 
1998; Deb et al., 2009, 2010). CTLs can attack neuronal so-
mata (Manning et al., 1987) and axons (Medana et al., 2001b) 
in primary neuronal cultures and explants, and cultured neurons 
are sensitive to lysis or silencing by perforin (Rensing-Ehl 
et al., 1996; Meuth et al., 2009). The Fas/Fas-L pathway can 
cause cytoskeleton breaks and membrane disruption which 
eventually cause neuronal death (Medana et al., 2000). How-
ever, the morphology, electrical activity, and glial cell environ-
ment of neurons differ considerably between in vitro culture 
conditions and the natural tissue habitat, and all of these 
factors can affect susceptibility to CTL attack (Neumann 
et al., 1995). Hence, we still lack a clear understanding of how 
CTLs damage neurons in vivo and which alterations result 
from such damage.
We have recently established the viral déjà vu model, al-
lowing us to study CTL-mediated neuronal damage and the 
resulting disease in vivo (Merkler et al., 2006). Neonatal intra-
cranial (i.c.) infection of mice with an attenuated lympho-
cytic choriomeningitis virus (LCMV) variant (rLCMV/INDG) 
results in viral persistence selectively in CNS neurons (a status 
referred to as carrier mice). rLCMV/INDG is not cytolytic 
and carrier mice are therefore clinically healthy, but they ex-
press viral nonself-antigens in neurons. Notably, they are free 
of CNS-infiltrating T cells, and viral epitope-specific CD8+  
T cell frequencies in peripheral blood remain below detection 
limits of peptide/MHC-I tetramer measurements (Merkler 
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We hypothesized that neuronal integration into synaptic 
networks rather than viability may be impaired as a result of 
CTL attack. Thus, we analyzed the density of dendrites on 
spinal cord motor neurons and counted perisomatic presynaptic 
boutons on neurons in the deep cerebellar nuclei (DCN). 
These anatomical areas represent components of important 
functional networks, display well defined cytological features 
(Garin and Escher, 2001), and can also be affected in human 
inflammatory CNS diseases (Dalmau and Rosenfeld, 2008; 
Gilmore et al., 2009). In healthy noncarrier controls, the 
somata of DCN were surrounded by so-called perisomatic 
boutons, i.e., punctate synaptophysin-positive areas corre-
sponding to putative synapses (Fig. 2 A). In contrast, the num-
ber of such boutons was significantly reduced in virus carriers 
with viral déjà vu disease. Such a reduction was preferentially 
observed on neurons, which expressed LCMV-NP—i.e., were 
antigenic targets for pathogenic CTLs—and were in direct 
contact with one or more T cells (Fig. 2 B). This suggested 
that perisomatic boutons were lost as a consequence of an 
Figure 1. Neuronal loss is observed in late stages of viral déjà vu 
disease. Adult carrier mice (+) and noncarrier controls () were subject 
to challenge (day 0) with LCMVwt (104 PFU) i.v. 3 or 8 wk later, neuronal 
density (NeuN+) was quantified in various brain and spinal cord areas as 
indicated in the graph. NeuN+ cells within these areas were detected  
using a computerized algorithm and expressed as cells per square milli-
meter. The anatomical areas under study are delimited by red lines,  
which were drawn according to anatomical landmarks. Error bars repre-
sent the mean + SEM of 4–12 mice per anatomical area and group. 
Shown are pooled data from two independent experiments. *, P < 0.05.
Figure 2. Deafferentation in viral déjà vu disease requires CTL con-
tact with infected neurons. (A–D) Carrier mice (C57BL/6 WT or YFP re-
porter mice) and noncarrier controls (without neonatal infection) were 
challenged with LCMVwt (104 PFU) i.v. in adulthood. (A) 10 d later, animals 
were sacrificed and brains were processed for histological analysis Left: 
representative section stained for synaptophysin+ perisomatic boutons 
(arrowheads) in the DCN of carrier and noncarrier mice 10 d after chal-
lenge. Right: quantification of perisomatic bouton density. Symbols repre-
sent individual animals. (B) On day 8 after challenge, CNS sections of DCN 
were triple immunostained for T cells, synaptophysin, and LCMV-NP anti-
gen (n = 4 animals). Perisomatic bouton density was quantified in LCMV-
NP–positive (+) neurons that were in juxtaposition to infiltrating T cells.  
(C) Dendritic projections into the spinal cord white matter in inflamed and 
noninflamed areas were quantified on MAP-2–immunostained sections  
(n = 4). (D) T cell infiltrates (CD3+, red) in the spinal cord of YFP-H mice 
(yellow subset of neurons). Proximity of T cells to somata of ventral horn 
neurons (left) and dendrites (middle) is shown. Dendrites without neigh-
boring T cells (right) are also shown. Monochromatic YFP images (middle 
and right only) illustrate dendrite morphology. Nuclei were visualized with 
neurotrace (NT). Error bars in B and C represent the mean + SEM of 4 mice 
per group. Bars: (A) 20 µm; (C, top) 200 µm; (C, bottom) 50 µm; (D, left)  
20 µm; (D, middle and right) 10 µm. One representative dataset out of two 
similar experiments is shown for A–D. **, P < 0.01.
epitope-specific targeted CTL attack. Conversely, the inflam-
matory milieu to which neighboring neurons (without direct 
CTL contact) were exposed in a “bystander” fashion was ap-
parently much less able to induce the observed alterations.
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Figure 3. Viral déjà vu disease depends on nonhematopoietic IFNGR but neither on Fas nor on perforin. Adult carrier mice and noncarrier con-
trols of the indicated genotypes were lethally irradiated and reconstituted with WT or perforin-deficient (PKO) bone marrow cells. Subsequently, mice were 
challenged with LCMVwt (104 PFU) i.v. Rotarod performance (A, B, and H), tissues, and brain-infiltrating CTLs (C–G) were analyzed at the peak of disease 
(day 10 after challenge). (A) Error bars represent the mean + SEM of 19–31 mice per group. (B) As a modification to the setup in A, all groups of mice were 
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given 104 P14xRAG splenocytes by adoptive transfer on day 1 of challenge (for details see Materials and methods). Error bars represent the mean + SEM 
of 4–8 mice per group. (C) Representative brain sections from the indicated experimental groups were stained for LCMV-NP antigen (top row) and infiltrat-
ing CTLs (bottom row). (D) Viral RNA load in brain was determined by TaqMan RT-PCR. Uninfected mice were tested for technical background determina-
tion. (E) Density of CD8+ T cell infiltrates in brain (cerebrum and cerebellum) as determined in histopathology. (F) Density of CD8+ T cell infiltrates inside 
inflammatory foci in DCN (not detectable in WT→TNFR1/2/ mice and thus not assessed [n.a.]). Error bars in D–F represent the mean + SEM of 3–7 ani-
mals per group. (G) Cytokine profile of brain-infiltrating NP396-specific (pathogenic) CD8+ T cells. Error bars show the mean + SEM of 2–4 mice per group. 
(H) Mice were infected and challenged as in A. Error bars represent the mean + SEM of 5–10 mice. Rotarod performance of the various experimental groups 
was compared with challenged WT→WT noncarrier controls. Bars: (C, top row) 200 µm; (C, bottom row) 50 µm. Shown are data pooled from five similar 
experiments (A), from one out of two similar experiments (B–F), or from one experiment (G and H), respectively. *, P < 0.05; **, P < 0.01.
 
Neurons not only receive afferent input at perisomatic 
synapses but mostly via their dendrites. Microtubule-associ-
ated protein 2 (MAP-2) is expressed in neuronal somata and 
dendrites (Johnson and Jope, 1992) and marks bundles of 
dendrites, which project into the ventro-lateral white matter 
of the spinal cord. Spinal cord segments that were diffusely 
infiltrated by CTLs exhibited significantly reduced dendrite 
densities (Fig. 2 C). Confocal microscopic analysis of fluores-
cently labeled neurons (Thy1-YFP-H reporter mice (Feng 
et al., 2000; Fig. 2 D) revealed that dendritic fragmentation 
was typically found in close spatial association with infiltrating 
T cells. Such neuronal deafferentation—rather than neuronal 
loss—occurred concomitantly with the early manifestations 
of viral déjà vu disease, thus representing a likely structural 
correlate thereof.
Nonhematopoietic IFN- receptors (IFNGRs),  
but neither Fas nor perforin, are necessary  
for viral déjà vu disease and neuronal deafferentation
Next, we analyzed the individual contribution of the CTL 
effector pathways FAS, perforin, IFN-, and TNF to disease 
manifestation. Defective Fas-, IFN-, or TNF signaling can 
hamper the induction, expansion, or maturation of CTLs 
(Watanabe-Fukunaga et al., 1992; Whitmire et al., 2005; Kim 
et al., 2006). Hence, we relied on bone marrow chimeric mice 
to perform these studies. Viral carriers lacking TNF receptors 
1 and 2 (TNFR1/2/), Fas (FAS/), or IFNGR/ and 
WT controls were lethally irradiated and reconstituted with 
WT bone marrow, such that the immune system was of  WT 
origin, but the respective receptor defects persisted in nonlym-
phohematopoietic cells of the CNS. Both WT→IFNGR/ 
and WT→TNFR1/2/ were protected from viral déjà vu 
disease, indicating that IFN- and TNF signaling in the CNS 
were necessary to precipitate neurological impairment (Fig. 3 A). 
In contrast, mice lacking FAS signaling (WT→FAS/) in 
the CNS showed unaltered susceptibility to viral déjà vu dis-
ease. Unlike the above receptor–ligand interactions, perforin-
dependent cytotoxicity operates independently of a cellular 
receptor but is generally considered a key effector mechanism 
of CTLs. A separate set of experiments established, however, 
that perforin deficiency did not affect disease manifestation 
either (Fig. 3 B). Differences in virus loads or CD8+ T cell re-
sponses between groups could have confounded the above 
experiments. When assessing the frequency of NP396-specific 
CTLs in peripheral blood, we found them spread out over a 
similar range in all experimental groups (P > 0.05 for all 
comparisons). Differences in the magnitude of CTL responses 
were therefore unlikely to account for differential disease 
susceptibility (unpublished data). Likewise, the assessment of 
rLCMV/INDG distribution and RNA loads in brain did not 
reveal any differences between groups, which could have ac-
counted for the resistance of WT→TNFR1/2/ or WT→
IFNGR/ mice to disease (Fig. 3, C and D). We quantified 
total CD8+ T cells in the CNS (Fig. 3 E) and separately also 
within inflammatory foci in the DCN (Fig. 3 F) where neu-
ronal alterations were prominent (compare with Fig. 2 B). 
Infiltrate densities were comparable in all carrier groups, with 
the notable exception of WT→TNFR1/2/ mice, in which 
CTL infiltration was virtually absent (Fig. 3, C–F). Transmigra-
tion of immune cells into the CNS requires TNF-dependent 
activation of the vascular endothelium (Kallmann et al., 2000), 
thus likely explaining the absence of CTL infiltrates in WT→
TNFR1/2/ carriers and resistance to disease. This prevented 
us from further analyzing a potential direct contribution of 
CTL-derived TNF to neuronal damage. Conversely, not only 
the number but also the functionality of brain-infiltrating 
CD8+ T cells in WT→IFNGR/ carriers was comparable 
to WT→WT controls, as judged by these cells’ ability to pro-
duce IFN- and TNF (Fig. 3 G). These observations sug-
gested that IFN- signaling to CNS-resident cells was essential 
for disease, and our previous work had documented that 
CNS-infiltrating CTLs associate preferentially with rLCMV/
INDG-infected neurons (Merkler et al., 2006). Hence, we in-
vestigated the possibility that IFN- acted on neurons.
Previous in vitro studies have shown that IFN- can in-
duce neuronal alterations in two distinct ways: first, IFN- 
can influence CTL–neuron interaction indirectly by up-reg-
ulating MHC-I expression on neurons and facilitate their 
recognition as CTL targets in vitro (Neumann et al., 1995). 
Second, IFN- can act as an effector cytokine to directly in-
duce neuronal pathology (Kim et al., 2002). To differentiate 
between these two possibilities, we exploited transgenic mice, 
which constitutively overexpress the MHC-I molecule H-2Db 
on neurons (NSE-Db transgenic mice; Rall et al., 1995). The 
NP396 epitope is presented on H-2Db and the respective 
CTLs drive viral déjà vu disease (Merkler et al., 2006), but 
constitutive H-2Db overexpression did not restore susceptibil-
ity to viral déjà vu disease in WT→IFNGR/ mice (Fig. 3 H). 
This suggested that IFN- caused disease irrespective of its 
role in neuronal MHC-I up-regulation.
In concordance with the clinical manifestations of disease, 
perisomatic bouton densities were reduced in inflammatory 
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immediate contact with infiltrating T cells (Fig. 5 D). Co-im-
munostaining revealed that 94.2 ± 0.1% of P-STAT1+ cells 
expressed the neuronal marker NeuN (mean ± SEM, n = 3 
animals; Fig. 5 E). Moreover, 73 ± 6.7% of these P-STAT1+ 
neurons expressed viral antigen (Fig. 5 E), as opposed to only 
29 ± 6.1% rLCMV/INDG-infected neurons overall, suggest-
ing an antigen-driven process. Besides STAT1, STAT3 can 
also signal downstream of the IFNGR (Ramana et al., 2002). 
However, only a minority of P-STAT3+ cells colocalized with 
the neuronal marker NeuN (11.2 ± 7.2%), and P-STAT3+ 
neurons were significantly less abundant (4.9 ± 1.7 cells/mm2) 
than P-STAT1+ neurons (30.4 ± 9.9 cells/mm2, P < 0.05). 
These observations suggested a T cell–driven IFN-–STAT1 
signaling pathway, which occurred preferentially in viral antigen-
expressing neurons.
Inflammatory infiltrates in the viral déjà vu model are 
dominated by CD8+ T cells (Merkler et al., 2006). Hence we 
set out to determine the role of CTL-derived IFN- in the 
disease process. After lethal irradiation, we reconstituted WT 
mice with a mixture of CD8/ bone marrow (2/3 of the 
transferred cells) plus either WT or IFN-–deficient (GKO) 
bone marrow (1/3 of the transferred cells). In the resulting 
foci of diseased WT→Fas/, PKO→PKO, and WT→WT 
controls but remained at normal levels in resistant WT→
IFNGR/ carriers (Fig. 4, A and B). Likewise, dendrites 
of WT→IFNGR/ mice remained at least partially con-
served upon challenge (Fig. 4, C and D). Collectively these 
results identified IFN- signaling as a main trigger of neu-
ronal deafferentation.
STAT1 up-regulation, phosphorylation, and nuclear 
translocation are hallmarks of IFN- signaling in neurons
We next investigated IFNGR downstream signaling by mea-
suring expression, phosphorylation, and nuclear translocation 
of the transcription factor STAT1 (Ramana et al., 2002). Stat1 
mRNA was significantly up-regulated in brains of WT→WT 
controls with viral déjà vu disease but not in resistant WT→
IFNGR/ mice (Fig. 5 A). Furthermore, numerous nuclei of 
WT→WT but not WT→IFNGR/ carriers contained phos-
phorylated (i.e., activated) STAT1 (P-STAT1) upon challenge 
(Fig. 5 B). Accumulations of P-STAT1+ cells were spatially 
associated with T cell clusters (Fig. 5 C), as revealed by com-
puter-based cluster analysis (for details see Materials and meth-
ods). Within these areas, P-STAT1+ cells were frequently in 
Figure 4. Deficiency in IFNGR signaling 
prevents perisomatic bouton loss in DCN and 
affords partial protection against dendritic 
alterations in spinal cord. Viral déjà vu experi-
ments were conducted with bone marrow chi-
meric carrier mice of the indicated genotypes 
and carrier state. At the peak of disease (day 10) 
synaptophysin+ perisomatic boutons on DCN 
neurons (A and B) and MAP-2+ dendritic pro-
cesses into the spinal cord white matter  
(C and D) were visualized by immunohistochem-
istry. (A) Representative picture of synaptophy-
sin+ boutons in DCN of the various experimental 
groups. Arrowheads indicate perisomatic bou-
tons of WT→WT noncarrier control animals and 
on neurons of WT→IFNGR/ mice. (B) Quanti-
tative analysis of perisomatic bouton density in 
the same animals as in A. Error bars indicate the 
mean + SEM of 3–7 mice per group. (C) Repre-
sentative pictures of spinal cord MAP-2 staining 
in the indicated groups. (D) Dendritic projections 
into the spinal cord white matter in WT→IF-
NGR/ and WT→WT areas were quantified on 
MAP-2–immunostained sections. Error bars 
represent the mean + SEM of three to six mice 
per group. Bars: (A) 10 µm; (C) 50 µm. Shown are 
representative data from one out of two similar 
experiments (A–D). *, P < 0.05; **, P < 0.01.
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Figure 5. STAT1 up-regulation, phosphorylation, and nuclear translocation reflect the neuronal signature of IFN- signaling. (A–H) Viral déjà 
vu experiments were conducted with bone marrow chimeric mice of the indicated genotypes and carrier state. Carrier mice and noncarrier controls were 
challenged with LCMVwt (104 PFU) i.v. in adulthood. Experiments were analyzed on day 10 after challenge. (A) STAT1 mRNA levels were assessed by qPCR. 
Error bars indicate the mean + SEM of 4–6 mice. (B) Immunohistochemistry for phosphorylated STAT1 (P-STAT1) was performed on brain sections of 
WT→WT carriers, WT→IFNGR/ carriers, and noncarrier controls. (C, left) T cell density map visualizes hot spots of inflammatory infiltrates. (C, right)  
P-STAT1+ neurons (visualized as purple spheres) within the same section. (D) Juxtaposition of P-STAT1+ (brown) cells and T cells (red) in challenged animals.  
(E, left) Colocalization of P-STAT1+ (red) with neurons (NeuN, green). (E, right) Colocalization of P-STAT1+ (red) with LCMV-NP (green). Arrows indicate 
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double-positive cells. 94% of P-STAT1+ cells were NeuN+ (616 neurons analyzed from three mice). 73% of P-STAT1+ neurons were LCMV-NP+ (105 neu-
rons analyzed from three mice). (F–H) Lethally irradiated WT mice, carriers or noncarriers, were reconstituted with either CD8/ plus IFN-–deficient 
(GKO) or CD8/ plus WT bone marrow at a 3:1 ratio (CD8/: GKO or CD8/: WT, respectively). Shown are rotarod performance (F), density of P-STAT1+ 
cells (G), and representative histological brain sections from the respective animals (H). Symbols represent the mean + SEM . Bars: (B) 70 µm; (C) 300 µm; 
(C, inset) 100 µm; (D and H) 50 µm; (D, inset) 10 µm; (E) 20 µm; (H, inset) 12.5 µm. HPF: high power field. A–D show representative data from one out of 
two similar experiments with 4–6 animals per group. E shows representative data from 3 animals per group and staining. Error bars in F and G represent 
the mean + SEM of 7–11 animals from one experiment. *, P < 0.05; **, P < 0.01.
 
GKO+CD8/→WT chimeric mice, CD8+ T cells were IFN-– 
deficient, whereas the majority of all other hematopoietic 
cells as well as nonhematopoietic cells were IFN-–competent. 
In control WT+CD8/→WT mice, all cell populations con-
tained a functional IFN- gene. When subjected to challenge, 
GKO+CD8/→WT chimeric mice, unlike WT+CD8/→
WT control mice, did not develop disease and did not show 
neuronal P-STAT1 expression (Fig. 5, F–H). This result dem-
onstrates that CD8+ T cell–derived IFN- is essential for 
neuronal STAT1 signaling and viral déjà vu disease.
To address whether IFNGR expression by virus-infected 
neurons was necessary for viral déjà vu disease, we used mice 
with a conditional allele of the IFNGR (IFNGRfl/fl). Neona-
tal inoculation of a recombinant rLCMV/INDG-expressing 
Cre recombinase (rLCMV-Cre) disrupted the IFNGR gene 
selectively in virus-infected cells (Fig. 6). To validate the ex-
perimental setting, we confirmed the cellular tropism and Cre 
recombinase activity of rLCMV-Cre in loxP-flanked RFP 
reporter mice (Luche et al., 2007). Co-immunostaining of 
LCMV-NP with the neuronal marker NeuN confirmed that 
rLCMV-Cre, like rLCMV/INDG (Merkler et al., 2006), per-
sisted exclusively in neurons (Fig. 6 A). Moreover, 99.0 ± 
0.6% of LCMV-NP+ neurons expressed RFP reporter, thus 
attesting to efficient LCMV-Cre–mediated recombination of 
loxP sites in vivo (Fig. 6 A). Indeed, WT but not IFNGRfl/fl 
carriers of rLCMV/IND-Cre developed viral déjà vu disease 
(Fig. 6 B) despite comparable CD8 T cell infiltrates in the 
CNS (Fig. 6, C,D, and G). Accordingly, the density of peri-
somatic boutons in rLCMVIND-Cre IFNGRfl/fl carriers re-
mained normal (Fig. 6, E and G), and only few P-STAT1+ 
cells were detected in the brain (Fig. 6, F and G). In a comple-
mentary approach, we crossed IFNGRfl/fl animals with mice 
constitutively expressing the Cre recombinase under a neuron-
specific Thy1 promoter (Thy1-cre x IFNGRfl/fl; Dewachter 
et al., 2002), thereby disrupting IFNGR signaling selectively 
in neurons. Thy1-Cre x IFNGRfl/fl mice were resistant to 
viral déjà vu disease (Fig. 6 H). Both experimental settings 
supported the conclusion that IFNGR signaling in virus- 
infected neurons was essential for the disease process.
IFN- blockade prevents neuronal deafferentation  
and clinical disease upon challenge but does not prevent 
lethal CTL-mediated choriomeningitis
The above findings in mice suggested that the IFN-–STAT1 
axis represented a conserved pathway to deafferentation, 
largely accounting for acute clinical disease upon CTL attack 
on neurons. Hence, we investigated whether this mechanistic 
knowledge could be translated into neuroprotective interven-
tion. Carrier mice were given IFN-–blocking antibody or 
isotype control treatment (Abrams et al., 1992) on day 5 after 
challenge, thus avoiding interference with the induction, ex-
pansion, or maturation of the CTL response (Fig. 7). Indeed, 
IFN- blockade did not alter the magnitude of NP396- 
specific CTL responses in peripheral blood of carrier mice 
(not depicted), but it protected against clinical manifestations 
of viral déjà vu disease (Fig. 7 A). Histological analysis showed 
that IFN- blockade did not affect CTL invasion into the 
CNS either (Fig. 7, B, C, and F) but prevented CTL-mediated 
deafferentation (Fig. 7, D and F). In support of our previous 
conclusions that IFN- accounted for neuronal STAT1 sig-
naling (Fig. 5), IFN- blockade prevented STAT1 phosphor-
ylation in neurons of mice after challenge (Fig. 7, E and F). In 
situ detection of the administered antibody confirmed its 
penetration into the inflamed CNS parenchyma of carriers 
with viral déjà vu disease (Fig. 7 G). Importantly, however, 
IFN- blocking antibody failed to afford any protection in 
the classical model of LCMV-induced choriomeningitis, an 
unrelated model of CNS disease; IFN--depleted (n = 4) and 
isotype antibody control-treated animals (n = 3) both devel-
oped terminal choriomeningitis within 6–7 d after i.c. infec-
tion with LCMVwt (unpublished data). In this archetypal 
disease model, the virus spreads inside the meninges, epen-
dyma, choroid plexus, and astrocytes forming the blood-brain 
barrier (but not in neurons as in the viral déjà vu setting), 
which then become targets of CTL attack (Cole et al., 1972). 
This confirmed that IFN-–blocking antibody administra-
tion on day 5 after challenge did not impair the pathogenic 
capacity of the ensuing CTL response altogether and, thus, 
that the IFN-–STAT1 axis was of selective importance for 
CTL attack on neurons but not for damage to other cell types 
of the CNS such as meninges and choroid plexus.
Neuronal deafferentation and IFN- signature  
are found in human RE
To investigate whether the neuronal IFN- signature ob-
served in the viral déjà vu model represented a common trait 
of CTL-mediated neurological disease, we analyzed brain 
biopsies of human patients suffering from RE. At the histo-
pathological level, RE is dominated by putatively antigen- 
specific CTL infiltrates in close association with CNS neurons 
(Schwab et al., 2009). Five out of six Rasmussen specimens 
displayed P-STAT1+ cells. CTLs were more diffusely dissemi-
nated, whereas P-STAT1+ cells were often clustered at various 
sites in the cerebral cortex and showed cellular colocalization 
 o
n
 D
ecem
ber 13, 2013
jem.rupress.org
D
ow
nloaded from
 
Published September 2, 2013
JEM Vol. 210, No. 10 
Article
2095
between different RE specimens, as expected for different 
disease stages (Pardo et al., 2004), and correlated positively 
with the density of P-STAT1+ neurons (P < 0.05, r2 = 0.76, 
with the neuronal marker NeuN (Fig. 8 A). Interestingly, 
P-STAT1+ neurons were often in close contact with CD8+  
T cells (Fig. 8 B). CTL infiltration density varied considerably 
Figure 6. Selective disruption of IFN- signaling in virus-infected neurons protects from clinical disease and neuronal deafferentation upon 
challenge. (A) Reporter mice expressing tandem RFP after Cre-mediated recombination were neonatally infected with Cre-expressing rLCMV/INDG (rLCMV-
Cre). Representative images of adult rLCMV-Cre carrier reporter mice show virus antigen (LCMV-NP, green) in neurons (NeuN, cyan) coexpressing RFP (red), 
thus confirming efficient virus-induced Cre-mediated recombination in infected neurons (at least 275 cortical neurons were evaluated from 3 mice each). 
(B–G) Adult WT noncarrier controls and rLCMV-Cre carrier mice with a conditional IFNGR allele (IFNGRfl/fl) or WT mice, respectively, were challenged with 
LCMVwt (104 PFU) i.v. Rotarod performance (B), brain-infiltrating CTL numbers (C and D), perisomatic bouton density in the DCN (E), and the density of 
cerebellar P-STAT1+ neurons (F) were analyzed at the peak of disease (day 10 after challenge). (G) Representative images of CTL infiltrates (top row), synap-
tophysin (middle row), and P-STAT1+ cells (bottom row) of the indicated groups. (H) Mice with disrupted IFNGR expression in neurons (Thy1-Cre x IFNGRfl/fl) 
mice were infected and challenged as in Fig. 2 A. Rotarod performance at the peak of disease (day 10 after challenge) is shown. Error bars represent the 
mean + SEM. HPF: high power field. Bars: (A; G, CD8 and P-STAT1) 25 µm; (G, synaptophysin) 10 µm. Data are from 9–11 animals per group for B, 3 animals 
for A, 4–5 animals for C–G, and 5–11 animals for H. Representative data from one out of two similar experiments are shown. *, P < 0.05; **, P < 0.01.
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Figure 7. IFN- blockade prevents neuronal deafferentation and clinical disease upon challenge. (A–E) Virus carriers and noncarrier controls 
were challenged with LCMV (104 PFU) i.v. 5 d later, IFN-–blocking antibody (XMG1.2, indicated as +) or isotype control antibody (indicated as –) was 
administered i.p. to carrier mice and noncarrier controls as indicated in the chart. Rotarod performance (A), brain-infiltrating CTL numbers (B, C, and F), 
perisomatic bouton density in the DCN (D and F), the density of cerebellar P-STAT1+ neurons (E and F), and in situ detection of anti–IFN-–blocking anti-
body (G) were analyzed at the peak of disease (day 10 after challenge). (F) Representative images of CTL infiltrates (top row), synaptophysin (middle row), 
and P-STAT1+ cells (bottom row) from the indicated groups are shown. (G) Representative images of in situ detected anti–IFN-–blocking antibody 
(brown reaction in top panel) and corresponding gradient map (bottom panel) of the indicated groups are shown. Error bars represent the mean + SEM. 
HPF: high power field. Bars: (F, CD8 and P-STAT1) 50 µm; (F, synaptophysin) 10 µm; (G) 2 mm. Data are from 6–9 animals per group for A–C, E, and G, and 
3–6 animals per group for D. F shows representative images from the animals evaluated in B–E. Representative data from one out of two similar experi-
ments are shown. *, P < 0.05; **, P < 0.01; n.a., not applicable.
n = 6 patients; Fig. 8 C). To investigate whether neuronal 
P-STAT1 expression was spatially associated with CTL in-
filtration, we generated a CTL density map from a repre-
sentative RE biopsy specimen (Fig. 8 D). Computational 
analysis confirmed that in analogy to the viral déjà vu setting 
(Fig. 5 C), 70% of P-STAT1 neurons were situated within 
CTL “hot-spots” which represented only a minute propor-
tion (0.12%) of the total biopsy area. In further analogy to 
the viral déjà vu model, the density of perisomatic synapses 
on P-STAT1–positive neurons was significantly reduced as 
compared with those on P-STAT1–negative neurons in close 
vicinity (Fig. 8 E).
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Figure 8. Neuronal STAT1 phosphorylation and reduced synaptic boutons in CD8+ T cell clusters of human RE. (A–E) Brain specimen from  
human RE. (A) Representative image of RE biopsy stained for CD8 (left) or P-STAT1 (right) on adjacent brain sections. Fluorescence inset shows cellular 
overlap of P-STAT1 (red) with neuronal marker NeuN (green). Arrows point to clusters of P-STAT1+ cortical neurons. (B) Co-immunostaining for CD8+ T cell 
infiltrates (brown) and P-STAT1 neurons (red) in inflamed and noninflamed brain area is shown. (C) Correlation between P-STAT1+ neurons and CD8+ T cell 
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infiltration density. Symbols represent individual RE patients (n = 6). (D, left) A CD8 density map visualizes CTL hot spots in a temporal lobe. (D, right)  
P-STAT1+ neurons (visualized as pink spheres) within the same biopsy. (E, left) Coimmunostaining of synaptophysin (red), P-STAT1 (green), and Neurotrace 
(cyan). Synaptophysin+ (red) perisomatic bouton density (arrowheads) on P-STAT1+ (green) is reduced as compared with P-STAT1 neurons. Arrow points 
to a T cell found in contact with a P-STAT1+ neuron. (E, right) Quantification of perisomatic bouton density. Symbols represent individual neurons. Bars: 
(A, overview and D, inset) 500 µm; (B, overview and A, inset) 50 µm; (B, inset and E, overview) 10 µm; (D, overview) 2 mm; (E, inset) 2 µm. Brain biopsies 
of 6 different RE patients were analyzed. *, P < 0.05.
 
DISCUSSION
The present study establishes deafferentation as an early mor-
phological consequence of CTL attack on neurons, both in 
mice and in humans, and identifies IFN- as the central mo-
lecular mediator in vivo. Together with our proof-of-principle 
for antibody blockade in mice, these findings delineate a di-
rect path to clinical translation. A humanized IFN- blocking 
antibody has previously demonstrated safety and efficacy in 
clinical trials for Crohn’s disease (Hommes et al., 2006; Reinisch 
et al., 2010), facilitating its exploratory administration for the 
treatment of RE and related immunological CNS disorders. 
Further, the intracellular signaling pathways downstream of 
the IFNGR are well characterized, comprising druggable 
targets (Platanias, 2005). Neuronal deafferentation apparently 
results from a fairly pinpointed attack by CTLs engaging 
antigen-expressing target neurons. Hence, IFN- blocking 
agents need to act at the CTL–neuron synapse and have to 
pass the blood-brain barrier. Small molecule inhibitors offer 
advantages in this regard, but antibodies can also pass at sites 
of inflammation, and thus may be selectively delivered to the 
appropriate place. Increased permeability of the blood brain 
barrier in typically young RE patients may further facilitate 
this process.
Our findings match previous in vitro observations that 
IFNGR-STAT1 signaling can cause dendritic retractions and 
inhibit synapse formation by cultured neurons (Kim et al., 
2002). Several mechanisms may account for this. First, IFN- 
can reduce cytoplasmic ATP levels (Mizuno et al., 2008), 
which may induce bioenergetic failure and ionic imbalances. 
Indeed, reduced ATP production is characteristic of neurons 
inside MS lesions (Dutta et al., 2006; Mahad et al., 2009; 
Campbell et al., 2011). Second, the IFNGR may form a com-
plex with the AMPA receptor subunit GluR1 in neurons, 
leading to increased excitability and vulnerability to glutamate 
excitotoxicity (Mizuno et al., 2008). It thus seems plausible 
that CTL-derived IFN- sensitizes inflamed brain regions 
to epileptic seizures, which represents the earliest and most 
prominent manifestation of RE (Rasmussen et al., 1958; Bien 
et al., 2005). Of note, our present findings offer a potential 
explanation for the disease-enhancing effects of IFN- in an 
exploratory trial for MS (Panitch et al., 1987), a disease with 
prominent dendritic pathology. With this postulate, we do 
not, however, mean to exclude the possibility that inhibitory 
effects of IFN- on remyelination (Lin et al., 2006) and/or its 
immunostimulatory activity may also contribute to the ad-
verse effects in MS.
Our observations may seem contradictory to earlier re-
sults emphasizing perforin- and Fas-dependent cytolysis of 
neurons (Medana et al., 2000; Meuth et al., 2009; Sobottka et 
al., 2009). Yet the viral déjà vu model is deliberately focused 
on the acute phase of CTL-mediated disease, which is of pri-
mary therapeutic relevance. Indeed, consequences of perfo-
rin- and/or Fas-mediated killing are likely more relevant in 
advanced stages of inflammatory CNS disease. Neuronal loss 
is a dominant feature in chronic but not acute stages of RE 
(Bien et al., 2002; Pardo et al., 2004) and was observed only 
late after challenge (Fig. 1). Deafferentation and cytolysis 
might thus represent sequential steps. Electrical silencing is 
known to render cultured neurons susceptible to CTL lysis 
(Neumann et al., 1995), but mechanisms of neuron silencing 
in vivo and its relevance have remained unclear. Our observa-
tions offer a unifying explanation: IFN- signaling in neurons 
may cause deafferentation, thus reducing synaptic drive below 
a critical threshold (Neumann et al., 1995). As a consequence 
and also driven by IFN- directly (Neumann et al., 1997), 
MHC-I expression may increase (Scheikl et al., 2012) and 
ultimately render neurons susceptible to perforin- or Fas- 
mediated cytolysis. Consistent with this concept, IFN- 
expression was found to be elevated in early RE, whereas ex-
pression of FAS ligand correlated with tissue destruction in 
later disease stages (Owens et al., 2013). Demyelination, as 
found in MS, may further facilitate lytic CTL attack by ex-
posing axons (Deb et al., 2009). Analogously, in vitro culture 
conditions may have facilitated neuronal cytolysis by CD8+ T 
cells (Medana et al., 2000; Meuth et al., 2009; Sobottka et al., 
2009), stressing the importance of a direct in vivo investiga-
tion of effector mechanisms as performed here.
Efficient CTL killing of virus-infected neurons would be 
to the obvious detriment of the host, and thus may have been 
selected against during evolution (Joly and Oldstone, 1992). 
Considering the severe consequences described here, the 
evolutionary conservation of neuronal IFN- sensing may 
come as a surprise. We propose that IFN- sensitivity was re-
tained to allow for noncytolytic viral clearance from neurons, 
a known key function of IFN- in the CNS (Binder and 
Griffin, 2001). It comes at the expense of isolating the respective 
neurons from their synaptic networks, which likely is revers-
ible (Zhang et al., 2005; Nikić et al., 2011). Hence, transient 
isolation of neurons from the circuits might represent an 
“affordable” strategy to clear viruses from infected neurons 
while avoiding the irreversible loss of these postmitotic cells. 
Conversely, therapeutic IFN- blockade could influence viral 
clearance (Binder and Griffin, 2001; Burdeinick-Kerr and 
Griffin, 2005). Collectively, the identification of CTL-driven 
neuronal deafferentation by the IFN- signaling pathway re-
casts our concept of “immune privilege” and host–pathogen 
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receptor-transgenic CD8+ T cell–containing splenocytes (P14xRAG) i.v. on 
day 1 of challenge. These RAG2-deficient and hence monoclonal cells re-
spond to an epitope derived from the LCMVwt glycoprotein, which is only 
expressed by the LCMVwt challenge but not by rLCMV/INDG persisting 
in virus carrier neurons. Hence, perforin-competent P14xRAG cells con-
trolled peripheral challenge with LCMVwt in PKO mice but they could not 
attack CNS neurons persistently infected with rLCMV/INDG. 4–8 wk after 
bone marrow reconstitution, the animals were challenged, i.e., 104 PFU 
LCMVwt was administered i.v. to trigger a vigorous NP396-specific CTL 
response. For in vivo blockade of IFN-, mice were given a single dose of 
2 mg rat anti–IFN- monoclonal antibody (clone: XMG1.2, BioXcell) or 
isotype control antibody (anti-HRPN; BioXcell) by i.p. administration on 
day 5 after challenge or i.c. (choriomeningitis model) infection.
Rotarod. The ability of motor coordination and balance of mice was moni-
tored with the rotarod test. In this assay, a mouse is placed on a rotating rod 
that gradually increases its speed of rotation. Thus, the locomotor perfor-
mance as measured by the time the animal stays on the rotating rod reflects 
the maximum rotation speed of the rod up to which the animal can stay in 
balance. Specifically, mice were placed on a rotating rod (Rotarod 7650; 
Ugo Basile Biological Research Apparatus) constantly accelerating from 4 to 
40 rounds per minute for a maximum of 180 s. Animals were habituated and 
trained to the rotarod daily from day 3 to day 0, as well on days 3, 5, and 
7–10. Endurance time was monitored, and the two best runs out of three at 
each time point were averaged for analysis. Values are displayed as percentage 
of healthy noncarrier controls on day 10.
Brain-extracted lymphocytes and flow cytometry. Lymphocytes were 
extracted from brains as described previously (Merkler et al., 2006). Epitope-
specific IFN- – and TNF-producing and MHC class I tetramer–binding 
CD8+ T cells were detected by flow cytometric analysis, as described pre-
viously (Probst et al., 2003). Allophycocyanin-conjugated anti–IFN-, FITC-
conjugated anti-TNF, PE-conjugated anti-CD8 and anti-CD8, and 
peridinin-chlorophyll protein–conjugated anti-B220 antibodies were pur-
chased from BD. The frequency of IFN-+CD8+ or tetramer+CD8+ cells was 
calculated as a percentage of CD8+B220 lymphocytes.
Histopathology. CNS tissue was either fixed with 4% paraformaldehyde or 
in HOPE fixative (DCS Innovative; Olert et al., 2001) and was embedded in 
paraffin as described previously (Bergthaler et al., 2007). For light microscopy, 
endogenous peroxidases (PBS/3% H2O2) were neutralized and unspecific 
binding blocked (PBS/10% FCS). PFA-fixed sections were stained with pri-
mary antibodies: rat anti–human CD3 (cross-reactive with murine T cells; 
Serotec), mouse anti-neuronal nuclei NeuN (EMD Millipore), rabbit anti–
Iba-1 (microglia/macrophages; Wako Chemicals USA), rat anti-LCMV nu-
cleoprotein sera (generated by prime-boost immunization against purified 
LCMV-NP), rabbit anti–phospho-STAT1 (detecting only phosphorylated 
STAT1 at position Tyrosine 701; Cell Signaling Technology), mouse anti–rat 
synaptophysin (cross-reactive with mouse; clone SY38c; Dako), and mouse 
anti–human CD8 (clone C8/114B; Dako). Hope-fixed sections were stained 
using rat anti–mouse CD8 antibody YTS169 and rat anti-LCMV nucleopro-
tein antibody (VL-4; Battegay et al., 1991). Rat anti–IFN- monoclonal anti-
body was detected in situ on hope-fixed sections using biotinylated anti–rat 
antibody. Bound primary antibodies were visualized either by an avidin- 
biotin technique with 3,3-diaminobenzidine or alkaline phosphatase/anti–
alkaline phosphatase as chromogens (haemalaun counterstaining of nuclei) 
for light microscopy or with the appropriate species-specific Cy2-, Cy3-, or 
Cy5-conjugated secondary antibodies (all from Jackson ImmunoResearch 
Laboratories, Inc.) with DAPI (Sigma-Aldrich) nuclei or Neurotrace (Invit-
rogen) nuclei/Nissl counterstaining for fluorescence microscopy.
Confocal microscopy. We obtained confocal images of fixed spinal cord 
sections of Thy1-YFP-H mice on an FV1000 confocal system mounted on 
an upright BX61 microscope (Olympus) equipped with 20×/0.85 and 
60×/1.42 oil immersion objectives. We recorded stacks of 12-bit images that 
interactions in the CNS, with potentially wide-ranging im-
plications for neuroprotective strategies in viral and auto-
immune CNS disease.
MATERIALS AND METHODS
Mice. Mice in this study included C57BL/6 WT mice, mice deficient for 
perforin (PKO; Kägi et al., 1994), TNF receptor 1 and 2 (TNFR1/2/; 
Peschon et al., 1998), Fas (FAS/; Adachi et al., 1995), or IFNGR/ 
(Huang et al., 1993), transgenic mice overexpressing the MHC class I mole-
cule H-2Db in neurons (NSE-Db; Rall et al., 1995; provided by D.B. McGavern 
and M.B.A. Oldstone, the Scripps Research Institute, La Jolla, CA), RAG2-
deficient (Shinkai et al., 1992) P14 TCR-transgenic mice (P14xRAG) ex-
pressing a TCR specific for amino acids 33–41 of the LCMV glycoprotein in 
the context of H-2Db (Pircher et al., 1989), Thy1-YFP-H mice, which ex-
press YFP in a subset of neurons (Feng et al., 2000), and Thy1-cre mice ex-
pressing the cre recombinase in neurons of the CNS (Dewachter et al., 2002; 
provided by M. Schwab, Brain Research Institute, University and ETH 
Zurich, Switzerland). Mice expressing the conditional IFNGR (IFNGRfl/fl) 
were generated by gene targeting in murine IDG32 F1 cells (provided by 
R. Kuhn, Helmholz Centre Munich, Germany) of the C57BL/6 × 129 strain 
and were backcrossed on C57BL/6 for eight generations. In the conditional 
allele, exons 4–6 are flanked by loxP sites. Deletion of these exons leads to 
inactivation of IFN- signaling. Cells with two floxed alleles signal compara-
bly to controls. Their full characterization will be published elsewhere. NSE-
Db x IFNGR/ and Thy1-Cre x IFNGRfl/fl were generated by intercrossing. 
All mice were generated on C57BL/6 or backcrossed on C57BL/6 back-
ground (eight or more generations). Animal experiments were performed 
at the Universities of Geneva and Zurich with authorization by the responsi-
ble Cantonal authority and in accordance with the Swiss law for animal pro-
tection, and at the University of Göttingen with authorization by the 
Bezirksregierung Braunschweig in accordance with the German law for ani-
mal protection.
Human tissue. Brain biopsies (n = 6) from patients with RE were obtained 
from the collection of the Department of Neuropathology at the Univer-
sitätsklinikum Erlangen. Patients 1–6 were 15, 8, 9, 3, 42, or 7 yr old with disease 
duration between 1 and 9 yr at the time of surgery. Their use for scientific pur-
poses was in accordance with institutional ethical guidelines and was approved 
by the ethics committee of the University of Göttingen (Germany).
Virus infection, titrations, and inoculations, and detection of viral 
RNA. A TaqMan RT-PCR protocol targeting the LCMV-NP gene 
(Pinschewer et al., 2010a) was used to quantify rLCMV/INDG S segment 
copies in the brain of infected mice. Arbitrary viral RNA units were deter-
mined in a multiplex assay with a commercial kit for detection of the house-
keeping gene GAPDH serving as internal reference (Applied Biosystems). 
Viruses were produced, titrated, and administered to mice as previously re-
ported (Merkler et al., 2006). For i.c. infection with LCMVwt the Armstrong 
strain was used at a dose of 103 PFU. Cre recombinase–expressing rLCMV-Cre 
was generated according to established procedures (Emonet et al., 2009).
Viral déjà vu setup, bone marrow reconstitution, and in vivo blockade 
of IFN-. Neonatal C57BL/6 (WT), IFNGR/, TNFR1/2/, FAS/, 
and PKO mice were infected with rLCMV/INDG i.c. to establish a viral 
carrier status in neurons as described previously (Merkler et al., 2006). Con-
trol groups of C57BL/6 mice were left uninfected at birth. At the age of 
5–6 wk, all mice were lethally irradiated. IFNGR/, TNFR1/2/, or 
FAS/ mice were reconstituted with C57BL/6 (WT) bone marrow and 
splenocytes. To have standardized conditions when assessing the role of per-
forin in viral déjà vu disease, PKO carrier mice were irradiated analogously 
to the other groups and were reconstituted with PKO bone marrow cells. As 
a complicating factor for this analysis, perforin-deficient (PKO) mice cannot 
control LCMVwt and develop severe wasting disease unrelated to the viral 
déjà vu pathology (Kägi et al., 1994). To reconstitute LCMVwt control 
in PKO mice, we adoptively transferred 104 perforin-competent P14 T cell 
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growing signal of neighboring T cell or reaching a maximal distance of 
30 pixels. The mean distance values at the border of two neighboring T cells 
was calculated and T cells were classified as follows: class I, distance value of 
<20 (human) or <25 (mouse) pixels (light green); class II, distance value be-
tween 10 and 15 (human) or 15 and 20 (mice) pixels (yellow); class III, dis-
tance values <10 (human) or <15 (mouse) pixels (red). T cells with distance 
value > 25 were considered as having no close neighbors. CD8 cluster were 
defined as groups of more than five T cells belonging to either of the afore-
mentioned class I–III. Furthermore, T cells situated within the perivascular, 
ependymal, or meningeal space were excluded from further analysis. The de-
tected T clusters were then superimposed onto the stained tissue to correlate 
the spatial distribution with detected P-STAT1 signals.
Statistical analysis. Analyses were performed with SPSS software (version 
12.0) and GraphPad Prism software (version 5.0). To assess significant differ-
ences between single measurements of two groups, two-tailed Student’s t tests 
were used, whereas differences between single measurements of more than 
two groups were assessed by one-way ANOVA followed by multiple t tests 
with Bonferroni’s adjustment for multiple comparisons if the F test of 
ANOVA indicated statistically significant differences. Two-way ANOVA was 
performed to test for differences between multiple measurements of two or 
more groups, again followed by multiple t tests with Bonferroni’s adjustment 
for multiple comparisons if the F test of ANOVA indicated statistically 
significant differences. For comparisons to reference values or to values of a 
control group, one-way ANOVA followed by Dunnett’s t tests were per-
formed. Viral RNA loads were log-transformed for statistical analysis. Re-
duction in motor performance was tested in comparison to values before 
disease onset (day 0), which were set to 100%. A p-value <0.05 was consid-
ered significant, and p-values <0.01 were considered highly significant, 
whereas p-values >0.05 were considered statistically not significant.
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